Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
54.48
+0.46 (0.85%)
At close: Apr 28, 2026, 4:00 PM EDT
55.00
+0.52 (0.95%)
After-hours: Apr 28, 2026, 4:33 PM EDT
Monopar Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 6.8 | 3.16 | 3.23 | 2.95 | 2.63 | |
| Research & Development | 9.9 | 13.01 | 5.6 | 7.59 | 6.49 | |
| Operating Expenses | 16.7 | 16.16 | 8.83 | 10.54 | 9.13 | |
| Operating Income | -16.7 | -16.16 | -8.83 | -10.54 | -9.13 | |
| Interest & Investment Income | 2.99 | 0.4 | 0.43 | 0.02 | 0.02 | |
| Other Non Operating Income (Expenses) | - | 0.17 | - | - | - | |
| EBT Excluding Unusual Items | -13.72 | -15.59 | -8.4 | -10.52 | -9.1 | |
| Pretax Income | -13.72 | -15.59 | -8.4 | -10.52 | -9.1 | |
| Net Income | -13.72 | -15.59 | -8.4 | -10.52 | -9.1 | |
| Net Income to Common | -13.72 | -15.59 | -8.4 | -10.52 | -9.1 | |
| Shares Outstanding (Basic) | 7 | 4 | 3 | 3 | 2 | |
| Shares Outstanding (Diluted) | 7 | 4 | 3 | 3 | 2 | |
| Shares Change (YoY) | 95.53% | 37.09% | 8.70% | 1.97% | 13.82% | |
| EPS (Basic) | -1.85 | -4.11 | -3.04 | -4.13 | -3.65 | |
| EPS (Diluted) | -1.85 | -4.11 | -3.04 | -4.13 | -3.65 | |
| EBIT | -16.7 | -16.16 | -8.83 | -10.54 | -9.13 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.